Molecular Partners Ag (MOLN) EBT Margin (2020 - 2024)
Molecular Partners Ag (MOLN) reported EBT Margin of -37433.33% for Q4 2024, down 35516.67 percentage points from -1916.67% a year earlier and down 35024.52 percentage points from the prior quarter.
Powered by 
Analysis
Molecular Partners Ag (MOLN) EBT Margin (2020 - 2024) Analysis & Trends
For FY2024, Molecular Partners Ag posted EBT Margin of -1080.82%, down 200.12 percentage points from FY2023.
- EBT Margin has a five-year change of -902.87 percentage points (FY2019 to FY2024).
- By year, EBT Margin came in at -880.70% in FY2023 (-942.86 pp), 62.16% in FY2022 (+716.08 pp), -653.92% in FY2021 (+17.91 pp) and -671.82% in FY2020 (-493.87 pp).
- The Q4 2024 figure ranks as the lowest quarterly EBT Margin in data going back to Q3 2020.
- Year over year, EBT Margin gained in three of the last eight quarters, with an average year-over-year change of -5008.54 percentage points.
- The high point for year-over-year EBT Margin in five years was Q4 2021 (a gain of 5737.66 percentage points); the low point was Q4 2024 (a drop of 35516.67 percentage points).
- Per Business Quant data, the three quarters before Q4 2024 came in at -2408.81% (Q3 2024), -972.40% (Q2 2024) and -413.62% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 40.25% |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 26.66% |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 25.18% |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | -4.11% |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 29.63% |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 18.19% |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 27.53% |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | -131.41% |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | -4.34% |
| 10 | Molecular Partners Ag | 138.65 Mn | -292.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -2,408.81% |
| Jun 30, 2024 | -972.40% |
| Mar 31, 2024 | -413.62% |
| Dec 31, 2023 | -1,916.67% |
| Sep 30, 2023 | -450.18% |
| Jun 30, 2023 | -3,852.29% |
| Mar 31, 2023 | -484.52% |
| Dec 31, 2022 | -646.51% |
| Sep 30, 2022 | -563.54% |
| Jun 30, 2022 | -38.46% |
| Mar 31, 2022 | 88.62% |
| Dec 31, 2021 | -992.63% |
| Sep 30, 2021 | -348.40% |
| Jun 30, 2021 | -494.56% |
| Mar 31, 2021 | -1,694.37% |
| Dec 31, 2020 | -6,730.29% |
| Sep 30, 2020 | 5,820.85% |
API Access
Molecular Partners Ag EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();